You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About NAYA Biosciences - Company Information, Overview, History and Profile

What does NAYA Biosciences do?

NAYA Biosciences Inc is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health. Its portfolio of assets currently includes NY-303, a GPC3 x NKp46 bifunctional antibody for the treatment of hepatocellular carcinoma (HCC) with a mode of action targeting non-responders to the current immunotherapy standard of care.

NAYA Biosciences Management structure

All Gross Remunerations are in USD
Mr. Steven M. Shum
Director and Chief Executive Officer
260 K
2024
Gross Remuneration
Year
Mr. Andrea Goren
Chief Financial Officer and Principal Accounting Officer
215 K
2024
Gross Remuneration
Year
Mr. Michael J. Campbell
Chief Operating Officer and Vice President, Business Development
192.5 K
2024
Gross Remuneration
Year
Mr. Daniel Gedeon Teper, M.B.A.,Pharm.D.
Director and President
137.55 K
2024
Gross Remuneration
Year

NAYA Biosciences Board of directors

All Gross Remunerations are in USD
Ms. Barbara Ryan
Independent Director
52.5 K
2024
Gross Remuneration
Year
Mr. Matthew K. Szot
Independent Director
47.5 K
2024
Gross Remuneration
Year
Mr. Trent D. Davis
Independent Director
42.5 K
2024
Gross Remuneration
Year
Ms. Rebecca Messina
Independent Director
42.5 K
2024
Gross Remuneration
Year
Mr. Daniel Gedeon Teper, M.B.A.,Pharm.D.
Director and President
-
2024
Gross Remuneration
Year
Ms. Lyn Falconio
Director
-
2024
Gross Remuneration
Year